David Wambeke
Corporate Officer/Principal at DIAMEDICA THERAPEUTICS INC.
Net worth: 1 M $ as of 2024-03-30
Profile
David John Wambeke is currently the Chief Business Officer at DiaMedica Therapeutics, Inc. He previously worked as a Partner & Managing Director at Craig-Hallum Capital Group LLC.
He completed his undergraduate degree at the University of Minnesota.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-15 | 527,114 ( 1.39% ) | 1 M $ | 2024-03-30 |
David Wambeke active positions
| Companies | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 2023-04-10 |
Former positions of David Wambeke
| Companies | Position | End |
|---|---|---|
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Craig-Hallum Capital Group LLC (Craig-Hallum) is an employee-owned, idea-driven research, trading and investment banking firm headquartered in Minneapolis, Minnesota. The firm was founded by Bradley Baker and Kevin Harris in 1997. Craig-Hallum provides research, institutional sales and trading and investment banking services to institutional investors and growth companies. | Analyst-Equity | 2023-02-28 |
Training of David Wambeke
| University of Minnesota | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Craig-Hallum Capital Group LLC (Craig-Hallum) is an employee-owned, idea-driven research, trading and investment banking firm headquartered in Minneapolis, Minnesota. The firm was founded by Bradley Baker and Kevin Harris in 1997. Craig-Hallum provides research, institutional sales and trading and investment banking services to institutional investors and growth companies. | Finance |
- Stock Market
- Insiders
- David Wambeke